Towards new approaches to disorders of fear and anxiety
Highlights
► We highlight new therapies for fear and anxiety from the connectome to epigenome. ► Optogenetic approaches will potentially be useful to treat fear and anxiety. ► Drugs that modify the epigenetic landscape hold therapeutic promise. ► Lifestyle interventions (e.g. diet, exercise, meditation) should be considered. ► Combinatorial approaches hold the most promise to alleviate fear and anxiety.
Section snippets
Towards new therapies for disorders of fear and anxiety
By recent estimates, 28% of the U.S. population suffers from some form of anxiety-related disorders during their lifetime [1]. These illnesses result in numerous adverse effects that extend from the impoverishment of the individual's quality of life to the high financial cost incurred to treat them. Understanding the functioning of the nervous system in a healthy and affected state will aid in the development of treatments for these disorders [2]. While the eventual goal of such investigation
Anxiety and fear: operational definitions
While the physical and psychological manifestations of anxiety and fear appear to share commonalities, they are in fact two independent entities that merit operational definitions. Anxiety is characterized as a state of being that arises from general and non-specific stimuli that are perceived as being potentially threatening in the future. This perception often results in an apprehensive mood accompanied by increased arousal and vigilance, which when taken to an extreme, persist for extended
Neural circuitry underlying anxiety and fear
As with any neuropsychiatric disorder, a constellation of brain regions underlie anxiety-like and fear-like states [14••, 15•, 16, 17, 18]. At the core of this is thought to be the ‘extended amydgala’ which includes the central (CeA) and medial (MeA) nuclei of the amygdala and the bed nucleus of the stria terminalis (BNST) (Figure 1). The extended amygdala is responsive to afferent input from the Basolateral Amygdala (BLA), and cortical regions such as the insular cortex. Divisions of the
Brain stimulation and optogenetics
There are many approaches ranging from current therapy and psychopharmacological treatments to future combination and brain-stimulation approaches that hold promise in the treatment of anxiety (Figure 3). Imaging studies have provided evidence to suggest that alteration of brain activity and structure within and between neural circuits plays a critical role in the manifestation of neuropsychiatric disorders [51, 52, 53]. Manipulating this altered brain activity using diverse techniques is
Disclosures
Dr. Ressler is a founding member of Extinction Pharmaceuticals/Therapade Technologies to develop d-cycloserine, a generically available compound, for use to augment the effectiveness of psychotherapy. He has received no equity or income from this relationship within the last three years.
References and recommended reading
Papers of particular interest, published within the period of review, have been highlighted as:
• of special interest
•• of outstanding interest
Acknowledgements
This work was supported through NIH (MH071537(KJR), MH096764 (KJR)) as well as the Burroughs Wellcome Fund. Support was received from the NIH/National Center for Research Resources base grant P51RR000165 to Yerkes National Primate Research Center.
References (80)
- et al.
Advances in multidisciplinary and cross-species approaches to examine the neurobiology of psychiatric disorders
Eur Neuropsychopharmacol
(2011) Animal models of anxiety: do I need multiple tests?
Trends Pharmacol Sci
(2008)- et al.
Anxiogenic effects of high illumination levels assessed with the acoustic startle response in rats
Biol Psychiatry
(1997) - et al.
Fear and anxiety: animal models and human cognitive psychophysiology
J Affect Disord
(2000) - et al.
Response variation following trauma: a translational neuroscience approach to understanding PTSD
Neuron
(2007) - et al.
What's wrong with my mouse model? Advances and strategies in animal modeling of anxiety and depression
Behav Brain Res
(2007) - et al.
A proposed test battery and constellations of specific behavioral paradigms to investigate the behavioral phenotypes of transgenic and knockout mice
Horm Behav
(1997) - et al.
Anxiogenic treatments do not increase fear-potentiated startle in mice
Biol Psychiatry
(2005) - et al.
Prefrontal control of fear: more than just extinction
Curr Opin Neurobiol
(2010) The amygdala
Curr Biol
(2007)
Corticotropin-releasing factor potentiates acoustic startle in rats: blockade by chlordiazepoxide
Psychopharmacology (Berl)
d-Cycloserine augmentation of behavioral therapy for the treatment of anxiety disorders: a meta-analysis
J Clin Psychiatry
The GABA system in anxiety and depression and its therapeutic potential
Neuropharmacology
The endocannabinoid system in anxiety, fear memory and habituation
J Psychopharmacol
Calcitonin gene-related peptide in the bed nucleus of the stria terminalis produces an anxiety-like pattern of behavior and increases neural activation in anxiety-related structures
J Neurosci
Posttraumatic stress disorder and the genetic structure of comorbidity
J Abnorm Psychol
MicroRNAs in learning, memory, and neurological diseases
Learn Mem
White matter integrity in highly traumatized adults with and without post-traumatic stress disorder
Neuropsychopharmacology
Recall of fear extinction in humans activates the ventromedial prefrontal cortex and hippocampus in concert
Biol Psychiatry
Neocortical excitation/inhibition balance in information processing and social dysfunction
Nature
Millisecond-timescale, genetically targeted optical control of neural activity
Nat Neurosci
Preventing the return of fear in humans using reconsolidation update mechanisms
Nature
Complementary medicine, exercise, meditation, diet, and lifestyle modification for anxiety disorders: a review of current evidence
Evid Based Complement Alternat Med
Lifetime prevalence and age-of-onset distributions of DSM-IV disorders in the National Comorbidity Survey Replication
Arch Gen Psychiatry
Cognitive dysfunction in psychiatric disorders: characteristics, causes and the quest for improved therapy
Nat Rev Drug Discov
The structure of common mental disorders
Arch Gen Psychiatry
Anxious responses to predictable and unpredictable aversive events
Behav Neurosci
Fear-potentiated startle in humans: effects of anticipatory anxiety on the acoustic blink reflex
Psychophysiology
Emotion circuits in the brain
Annu Rev Neurosci
Phasic vs sustained fear in rats and humans: role of the extended amygdala in fear vs anxiety
Neuropsychopharmacology
Neuronal signalling of fear memory
Nat Rev Neurosci
Emotion and cognition: insights from studies of the human amygdala
Annu Rev Psychol
New perspectives in basal forebrain organization of special relevance for neuropsychiatric disorders: the striatopallidal, amygdaloid, and corticopetal components of substantia innominata
Neuroscience
Prelimbic cortical BDNF is required for memory of learned fear but not extinction or innate fear
Proc Natl Acad Sci U S A
Neurons in medial prefrontal cortex signal memory for fear extinction
Nature
The neurocircuitry of fear, stress, and anxiety disorders
Neuropsychopharmacology
Cell-type specific deletion of GABA(A)alpha1 in corticotropin-releasing factor-containing neurons enhances anxiety and disrupts fear extinction
Proc Natl Acad Sci U S A
The benzodiazepine alprazolam dissociates contextual fear from cued fear in humans as assessed by fear-potentiated startle
Biol Psychiatry
A meta-analysis of d-cycloserine and the facilitation of fear extinction and exposure therapy
Biol Psychiatry
Neuropeptide regulation of fear and anxiety: implications of cholecystokinin, endogenous opioids, and neuropeptide Y
Physiol Behav
Cited by (64)
Genetic disruption of dopamine β-hydroxylase dysregulates innate responses to predator odor in mice
2024, Neurobiology of StressEpigenetic mechanisms regulate cue memory underlying discriminative behavior
2022, Neuroscience and Biobehavioral ReviewsCitation Excerpt :This differs from studies using an olfactory model that show trans- and inter-generational effects of olfactory learning that are associated with heritable DNA methylation events (for review, see Dias and Ressler, 2014). These elegant trait inheritance studies show that epigenetic mechanisms can alter perceptual acuity by modifications to the number and sensitivity of receptors in the olfactory bulb in the progeny of odor-cue trained animals, without actual transfer of the learned discriminative behavior itself (Dias et al., 2013, 2015; Klengel et al., 2016). These studies are particularly useful in behavioral epigenetic study because of the one-to-one mapping of gene to odorant receptor.
Habenula orphan G-protein coupled receptors in the pathophysiology of fear and anxiety
2022, Neuroscience and Biobehavioral ReviewsCitation Excerpt :Pavlovian fear conditioning has been used to assess the network of associated brain structures that convert sensory input into specific behavioral output and quantify this function by harnessing learning and memory tasks. At the core of this is the distributed network of brain regions comprising the amygdala with its extension the central and medial nuclei of the amygdala and the bed nucleus of the stria terminalis (BNST) (Dias et al., 2013; Kim et al., 2013). The novel aspects of specific circuits underlying anxiety-like behavior are more complex than those dedicated to fearful stimuli.
A randomised, double-blind, placebo-controlled trial, assessing the effect of a nutraceutical tablet in the management of stress in pet dogs
2021, Applied Animal Behaviour ScienceEndocannabinoids, cannabinoids and the regulation of anxiety
2021, Neuropharmacologyβ-sitosterol reduces anxiety and synergizes with established anxiolytic drugs in mice
2021, Cell Reports Medicine